Concerns about medical malpractice claims and skyrocketing liability insurance costs are causing ob/gyns to change the way they practice, says a national survey of ACOG members.
According to the survey, the risk of liability claims has caused ACOG Fellows to decrease their participation in high-risk obstetric care by 22%, stop performing vaginal births after Cesarean births (14.8%), and stop practicing obstetrics altogether (14%). In addition, respondents cited the lack of affordable medical malpractice insurance as the reason they've cut back on providing high-risk obstetric care (25.2%), gynecologic surgical procedures (14.8%), and deliveries (12.2%).
The survey also found that ob/gyns faced more obstetric claims (61%) than gynecologic claims (38%). The most frequently cited obstetric claims involved neurologically impaired infants (34%), followed by stillbirths or neonatal death (15%). The most frequently cited gynecologic claims involved a delay or failure to diagnose (29%), followed by major and minor patient injury (25% and 15%, respectively).
On the brighter side, almost half of all claims against ob/gyns are dropped, dismissed, or settled without payment. Of the cases that do wind up in court, judgments are made in favor of the ob/gyn 8 out of 10 times.
Severe maternal morbidity linked to mental health risks post-delivery
April 26th 2024A recent study revealed that severe maternal morbidity during pregnancy increases the likelihood of mental health hospitalizations or emergency department visits up to 13 years post-delivery, emphasizing the need for mental health screening.
Read More
FDA approves updated label for Biktarvy against HIV-1
April 26th 2024Gilead Sciences has announced FDA approval of an updated Biktarvy label, showcasing safety and efficacy data from a phase 1b trial, positioning it as a pivotal treatment option for pregnant individuals with HIV-1 and suppressed viral load.
Read More
No link found between antenatal corticosteroids and child neurodevelopment
April 25th 2024A recent study found no link between antenatal corticosteroid administration and adverse neurodevelopmental outcomes in children aged 6 years or older, offering reassurance for late preterm delivery practices.
Read More